MDGL
Madrigal Pharmaceuticals Inc (MDGL)
Healthcare • NASDAQ • $446.20-1.11%
Key Fundamentals
- Symbol
- MDGL
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $446.20
- Daily Change
- -1.11%
- Market Cap
- $10.39B
- Trailing P/E
- N/A
- Forward P/E
- 46.73
- 52W High
- $615.00
- 52W Low
- $393.61
- Analyst Target
- $685.78
- Dividend Yield
- 0.00%
- Beta
- -1.05
About Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Company websiteResearch MDGL on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.